STOCK TITAN
  1. Home
  2. Sec-filings
  3. AXON
  4. [8-K] AXON ENTERPRISE, INC. Reports Material Event

Axon (NASDAQ: AXON) director Julie Anne Cullivan decides not to seek re-election

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Axon Enterprise, Inc. reported that director Julie Anne Cullivan has informed the Board that she will not stand for re-election at the company’s 2026 Annual Meeting of Shareholders. She will continue to serve as a director until her current term expires at that meeting.

The company states that Ms. Cullivan’s decision is not due to any disagreement with Axon regarding its operations, policies, or practices. The Board expressed strong appreciation for her commitment, leadership, and contributions to Axon’s growth and progress during her years of service.

Positive

  • None.

Negative

  • None.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Understanding 8-K Material Events →
0001069183FALSE00010691832026-03-052026-03-05

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
________________________________________________________
Form 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
March 5, 2026
Date of Report (Date of earliest event reported)
________________________________________________________
Axon Enterprise, Inc.
(Exact name of registrant as specified in its charter)
Delaware001-1639186-0741227
(State or other jurisdiction of
incorporation)		(Commission File Number)(IRS Employer
Identification No.)
17800 N. 85th St.
Scottsdale, Arizona 85255
(Address of principal executive offices, including zip code)
(480) 991-0797
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $0.00001 Par ValueAXONThe NASDAQ Stock Market LLC
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
oWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
oSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
oPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
oPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth company o
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o


Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On March 5, 2026, Julie Anne Cullivan notified the Board of Directors (the “Board”) of Axon Enterprise, Inc. (the “Company”) that she will not stand for re-election as a director at the Company’s 2026 Annual Meeting of Shareholders (the “Annual Meeting”). Ms. Cullivan will continue to serve as a director until her term expires at the Annual Meeting. Ms. Cullivan’s decision not to stand for re-election was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.

The Board greatly appreciates Ms. Cullivan’s deep commitment, leadership and many contributions to the Board and to the Company’s growth and progress during her years of service.


SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: March 11, 2026Axon Enterprise, Inc.
By: /s/ ISAIAH FIELDS
Isaiah Fields
Chief Legal Officer and Corporate Secretary

Source: View Original Filing on SEC EDGAR

FAQ

What board change did Axon (AXON) disclose in this 8-K filing?

Axon disclosed that director Julie Anne Cullivan will not stand for re-election at the 2026 Annual Meeting of Shareholders. She will remain on the Board until her current term expires at that meeting, ensuring continuity during the transition period.

Why is Axon director Julie Anne Cullivan leaving the Board?

Axon states that Julie Anne Cullivan chose not to stand for re-election at the 2026 Annual Meeting. The company specifically notes her decision was not due to any disagreement about Axon’s operations, policies, or practices, indicating an orderly and amicable transition.

When will Julie Anne Cullivan’s term as Axon (AXON) director end?

Julie Anne Cullivan’s term will end at Axon’s 2026 Annual Meeting of Shareholders. She will continue serving as a director until that meeting, providing ongoing participation in Board activities and governance through the remainder of her elected term.

Did Axon report any disagreement with Julie Anne Cullivan in this 8-K?

No. Axon explicitly states that Ms. Cullivan’s decision not to stand for re-election was not the result of any disagreement with the company on operations, policies, or practices, suggesting her departure is not tied to a governance or policy dispute.

How did Axon’s Board characterize Julie Anne Cullivan’s service?

Axon’s Board expressed strong appreciation for Julie Anne Cullivan’s service, highlighting her deep commitment, leadership, and contributions to the company’s growth and progress. This language underscores a positive assessment of her tenure and a respectful Board relationship.

What SEC item does Axon use to report this board change?

Axon reported this information under Item 5.02, which covers departures and elections of directors, appointments of certain officers, and related compensatory arrangements. This item is commonly used to disclose material changes in board or senior officer roles.

Filing Exhibits & Attachments

3 documents

Other Documents